Evolent Health Inc (NYSE:EVH) currently has a daily average trading volume of 942.31K but it saw 935296 shares traded in last market. With a market cap of 3.17B USD, the company’s current market price of $27.27 came falling about -1.23 while comparing to the previous closing price of $27.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $35.83 and as low as $23.33.
Taking a look at 20-day trading activity of Evolent Health Inc (EVH) gives us an average price of $28.73, while its current price level is -23.89% below from 52-week high level whereas it is 16.89% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $31.04 while that of 200 days or SMA-200 reads an average of $29.25. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.71% during that period while stretching the period over a month that increases to 2.86%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.57 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Citigroup which initiated the stock as “Buy” in its note to investors issued on April 22, 2024, recommending a price target of $40 for it. Barclays also issued its recommendations for the stock as it initiated the price target for the stock is $39.
Year-to-date it is -17.44% down and over the past year, the stock is showing a downside performance of -21.48%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 0.21 beat the consensus estimate of 0.2 for the same. In next quarter, company is expected to be making quarterly sales of $606.64M as analysts are expecting the sales for current fiscal year at $2.47B and seeing the company making $2.86B in sales next year. Moreover, analysts are in estimates of $600.82M for current-quarter revenue.
Currently, Evolent Health Inc’s total number of outstanding shares is 113.89M. Company’s return on investment (ROI) stands at -7.56% and return on equity (ROE) at -11.73%. It has a 18.11 of forward P/E ratio. Stock’s beta reads 1.50. Stock has a price to book (P/B) ratio of 2.91 while price to sale or P/S ratio amounts to 1.61. Its return on asset (ROA) is -5.03% on average.
